Surgery Doctors in Kenner, LA Accepting Medicare

6 Surgery doctors found. Showing 1 - 6

Dr. Wagih R Mando, M.D Surgery Medicare: Not Enrolled in Medicare Practice Location: 200 W Esplanade Ave, Suite 410, Kenner, LA 70065 Phone: 504-464-8619    Fax: 504-464-4876

Dr. John Philip Boudreaux, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 W Esplanade Ave, Suite 200, Kenner, LA 70065 Phone: 504-464-8500    Fax: 504-464-8525

Ramcharan Thiagarajan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 W Esplanade Ave, Ste 200, Kenner, LA 70065 Phone: 504-464-8701    Fax: 504-464-8525

Dr. Eugene Anthony Woltering, MD Surgery Medicare: Medicare Enrolled Practice Location: 200 W Esplanade Ave, Sutie 200, Kenner, LA 70065 Phone: 504-464-8500    Fax: 504-646-8525

Dr. Mohammad S. Suleman, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 W Esplanade Ave, Ste 312, Kenner, LA 70065 Phone: 504-712-8872    Fax: 504-712-8879

Clint Sumbera Schoolfield Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 W Esplanade Ave Ste 401, Kenner, LA 70065 Phone: 504-464-8588

News Archive

Exposure to daylight helps protect children from myopia

Two new studies add to the growing evidence that spending time outdoors may help prevent or minimize nearsightedness in children. A study conducted in Taiwan, which is the first to use an educational policy as a public vision health intervention, finds that when children are required to spend recess time outdoors, their risk of nearsightedness is reduced.

New research reveals overlooked impact of herbicide glyphosate on the environment

New research from McGill University reveals an overlooked impact that the widely used herbicide glyphosate may be having on the environment.

Global research initiative to improve health care for people with MNS disorders

Mental health experts are calling for a greater world focus on improving access to care and treatment for mental, neurological, and substance use (MNS) disorders, as well as increasing discoveries in research that will enable this goal to be met.

Cortex Pharmaceuticals receives delisting notification from NYSE Amex

Cortex Pharmaceuticals, Inc. (NYSE Amex (COR)) reported that it has received a delisting notification from the NYSE Amex LLC indicating that it has not accepted the Company's plan to regain compliance with the Exchange's continued listing standards, as submitted by the Company in June.

Read more Medical News

› Verified 3 days ago